Results per Page:
Dying cells signal the thymus to rebuild
From the Dudakov Lab, Translational Science and Therapeutics Division
Reading between the cells: How MRD details predict AML relapse
From the Walter Lab, Translational Science and Therapeutics Division
Carrera contra reloj: Cronogramas más cortos mejoran las predicciones de la gripe
Del Laboratorio Bedford, Departamento de Vacunas y Enfermedades Infecciosas
Extramedullary disease shapes toxicity risk in BCMA CAR T therapy
From the Gauthier Group, Clinical Research Division
Giving CAR T a second life in osteosarcoma
From the Meshinchi Lab, Clinical Research Division and Translational Science and Therapeutics Division
Down to the wire: Shorter timelines make better flu predictions
From the Bedford Lab, Vaccine and Infectious Disease Division
Hidden reactivation, active immunity: Mapping the immune response to HSV-2
From the Lund Lab, Vaccine and Infectious Disease Division
Foot on the gas: How RIT1 and YAP accelerate lung adenocarcinoma
From the Berger Lab, Human Biology Division
A moving target: How spike’s shape determines immune escape in SARS-CoV-2
From the Bloom Lab, Basic Sciences Division
AMOTL2 multitasks to control cell growth and Zika virus infection
From the Overbaugh Lab, Human Biology Division
A cellular epic starring eIF1 and eIF5
From the Lapointe Lab, Basic Sciences Division
Del tratamiento a la transición: Apoyo a la atención primaria en la supervivencia del cáncer
De la Dra. Jean Yi y sus colegas del Consorcio Oncológico de UW y Fred Hutch
Tracking rhabdomyosarcoma’s return: A focus on gene fusions
From the Mian Lab, Precision Radiation Sciences Lead Radiation Oncology Division and the Cancer Consortium
Robarle una base al cáncer: la edición de precisión para una inmunoterapia más segura
Del Laboratorio Kiem, División de Ciencias Traslacionales y Terapéuticas
From treatment to transition: Supporting primary care in cancer survivorship
From Dr. Jean Yi and colleagues at the UW & Fred Hutch Cancer Consortium
Stealing a base from cancer: precision editing for safer immunotherapy
From the Kiem Lab, Translational Science and Therapeutics Division
Glitch to switch: Turning spliceosome mutations into immune targets
From the Bleakley Lab, Translational Science and Therapeutics Division
DUX in a row: Exploring genetic repression across the D4Z4 repeat
From the Tapscott Lab, Clinical Research and Human Biology Divisions
Going beneath the skin: A closer look at serositis in cGVHD
From the Lee Lab, Clinical Research Division
Microbes behind the malodor: cross-feeding in bacterial vaginosis
From the Fredricks Lab, Vaccine and Infectious Disease Division